15.11.2012 Views

Medicinal Plants Classification Biosynthesis and ... - Index of

Medicinal Plants Classification Biosynthesis and ... - Index of

Medicinal Plants Classification Biosynthesis and ... - Index of

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

168<br />

V<strong>and</strong>ana Gulati, Ian H. Harding <strong>and</strong> Enzo A. Palombo<br />

prevention <strong>and</strong>/or treatment <strong>of</strong> diabetes. Intriguing questions that await further<br />

elucidation include how plants, plant-derived molecules <strong>and</strong> diet can be used in the future<br />

to complement current treatment strategies for diabetes.<br />

Introduction<br />

Diabetes mellitus is a metabolic syndrome which results from low levels <strong>of</strong> insulin when<br />

β cells <strong>of</strong> the pancreas are not able to secrete sufficient insulin. The symptoms <strong>of</strong> diabetes are<br />

hyperglycemia (high blood glucose), polyuria (increase in urine production), polydipsia<br />

(increased thirst), blurred vision, lethargy <strong>and</strong> weight loss. The increasing worldwide<br />

incidence <strong>of</strong> diabetes mellitus in adults constitutes a global public health burden. It is<br />

predicted that by 2030, India, China <strong>and</strong> United States will have largest number <strong>of</strong> people<br />

with diabetes (1, 2). The World Health Organization (WHO) estimates that more than 180<br />

million people worldwide currently have diabetes <strong>and</strong> this figure is likely to more than<br />

double by 2030. In 2005, an estimated 1.1 million people died from diabetes <strong>and</strong> almost 80%<br />

<strong>of</strong> diabetes deaths occurred in low <strong>and</strong> middle-income countries. Almost half <strong>of</strong> diabetes<br />

deaths occur in people under the age <strong>of</strong> 70 years; 55% <strong>of</strong> diabetes deaths are in women <strong>and</strong><br />

the WHO projects that diabetes death will increase by more than 50% in the next 10 years<br />

without urgent action. Most notably, diabetes deaths are projected to increase by over 80% in<br />

upper-middle income countries between 2006 <strong>and</strong> 2015 (3).<br />

Over time, diabetes can damage the heart, blood vessels, eyes, kidneys, <strong>and</strong> nerves. The<br />

major complications related to diabetes are diabetic retinopathy, a cause <strong>of</strong> blindness which<br />

results from long-term accumulated damage to the small blood vessels in the retina, <strong>and</strong><br />

diabetic neuropathy, the destruction <strong>of</strong> nerves as a result <strong>of</strong> diabetes with common symptoms<br />

<strong>of</strong> tingling, pain, numbness, or weakness in the feet <strong>and</strong> h<strong>and</strong>s. Combined with reduced blood<br />

flow, neuropathy in the feet increases the chance <strong>of</strong> foot ulcers <strong>and</strong> eventual limb amputation.<br />

Diabetes is among the leading causes <strong>of</strong> kidney failure <strong>and</strong> increases the risk <strong>of</strong> heart disease<br />

<strong>and</strong> stroke. Ten to twenty percent <strong>of</strong> people with diabetes die <strong>of</strong> kidney failure <strong>and</strong> fifty<br />

percent <strong>of</strong> people with diabetes die <strong>of</strong> cardiovascular disease (primarily heart disease <strong>and</strong><br />

stroke). The overall risk <strong>of</strong> dying among people with diabetes is at least double the risk <strong>of</strong><br />

their peers without diabetes (3).<br />

[153] Diabetes is categorized into: Type I – Insulin Dependent Diabetes Mellitus (IDDM) –<br />

which is an autoimmune destruction <strong>of</strong> pancreatic β cells; Type II – Non-Insulin<br />

Dependent Diabetes Mellitus (NIDDM) – which is characterized by insulin resistance<br />

in target tissues; <strong>and</strong> gestational diabetes which occurs during pregnancy.<br />

In Type I diabetes, there is loss <strong>of</strong> insulin secreting β cells <strong>of</strong> the Islets <strong>of</strong> Langerhans in<br />

the pancreas which causes deficiency <strong>of</strong> insulin. The main cause <strong>of</strong> β-cell loss is autoimmune<br />

attack <strong>of</strong> T-cells. The principal treatment is replacement <strong>of</strong> insulin.<br />

Type II diabetes is caused by reduced insulin sensitivity due to increased glucose levels<br />

in the blood. Hyperglycemia can be rectified by medications that improve insulin sensitivity<br />

or decrease glucose production by the liver. This condition can be treated by increasing<br />

physical activity, decreasing carbohydrate intake, selection <strong>of</strong> proper diet, modification <strong>of</strong><br />

life-style <strong>and</strong> losing weight.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!